Clinical Trial Update: TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

This update describes a Phase 1 clinical trial evaluating a TRAIL-R2 and HER2 bi-specific CAR T cell therapy for metastatic breast cancer; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TRAIL-R2 and HER2 Bi-Specific CAR T Cells

Snippet

Sponsor: Baylor College of Medicine | Conditions: Breast Cancer, Tumor, Breast | Phase 1 | Status: NOT_YET_RECRUITING